On Target Laboratories Announces Expanded Indication of CYTALUX® (pafolacianine) injection for Detection of Lung Cancer During Surgery

/PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing intraoperative molecular imaging agents to target and...

Related Keywords

United States ,Danielle Kirsch ,Chris Barys ,Sunil Singhal ,Ralphc Corley ,Jessica Todd ,Linda Martin ,William Maul Measey Professor In Surgical Research ,National Cancer Institute ,World Health Organization ,Drug Administration ,University Of Virginia School Medicine ,Syneos Health ,Laboratories Inc ,Purdue University Presidential Scholar For Drug Discovery ,Target Laboratories ,Multichannel News Release ,Chief Executive Officer ,Thoracic Surgery ,Virginia School ,Principal Investigator ,William Maul Measey Professor ,Surgical Research ,Precision Surgery ,Penn Medicine ,Molecular Imaging ,Purdue University ,Presidential Scholar ,Drug Discovery ,Distinguished Professor ,Prescribing Information ,Cancer Stat Facts ,Accessed December ,International Agency ,Cancer Global ,Accessed May ,Lung Cancer ,Localize Pulmonary ,On Target Laboratories ,Nc ,